Medplus Health to acquire 0.01% residual stake in Optival Health Solutions, making it wholly owned subsidiary
Medplus Health Services Limited will acquire the remaining 0.01% stake in Optival Health Solutions Private Limited for ₹1.10 crore, making it a wholly owned subsidiary. Optival Health Solutions reported a turnover of ₹6816.44 crore in FY 2025-26.
The acquisition of a small residual stake to achieve 100% ownership is a positive step but is unlikely to have a significant immediate financial impact given the small percentage and value involved.
The acquisition of the remaining stake to make a subsidiary wholly owned is generally viewed positively as it increases control and simplifies reporting.
Medplus Health Services Limited announced today, September 10, 2026, that its Board of Directors has approved the acquisition of the remaining 0.01% stake in its material subsidiary, Optival Health Solutions Private Limited. This acquisition, from the remaining shareholders, will increase Medplus's shareholding in Optival from 99.99% to 100%, consequently making Optival a wholly owned subsidiary.
The acquisition involves 17,986 equity shares of Optival Health Solutions Private Limited, with a face value of ₹10 each. The aggregate consideration is ₹1.10 crore, subject to mutual negotiation and agreement.
Optival Health Solutions Private Limited operates in the pharmacy retail business and was incorporated on July 11, 2005. As of March 31, 2026, its authorized share capital was ₹210 crore and paid-up share capital was ₹209.80 crore. Its turnover for FY 2025-26 was ₹6816.44 crore, for FY 2024-25 it was ₹6058.59 crore, and for FY 2023-24 it was ₹5573.08 crore. The company has its registered office in Hyderabad, Telangana, and operates in India.
This acquisition is not a related party transaction. The board meeting commenced at 11:00 AM and concluded at 1:00 PM. The company expects to complete the acquisition expeditiously, subject to requisite documentation and formalities.
What to do with a filing like this
Medplus Health Services Limited filed this with the NSE as a statutory disclosure, categorised under other corporate actions. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Medplus Health Services Limited. Read the original for the full detail.